4-(1-Pyrrolidinyl)piperidine - CAS 5004-07-9
Catalog: |
BB026903 |
Product Name: |
4-(1-Pyrrolidinyl)piperidine |
CAS: |
5004-07-9 |
Synonyms: |
Piperidine, 4-(1-pyrrolidinyl)-; 1-(Piperidin-4-yl)pyrrolidine; 4-(1-Pyrrolidino)piperidine; 4-(Pyrrolidinyl)piperidine; 4-Pyrrolidinopiperidine |
IUPAC Name: | 4-pyrrolidin-1-ylpiperidine |
Description: | 4-(1-Pyrrolidinyl)piperidine (CAS# 5004-07-9) is used in the synthesis of Monensin A esters as antibiotics. |
Molecular Weight: | 154.25 |
Molecular Formula: | C9H18N2 |
Canonical SMILES: | C1CCN(C1)C2CCNCC2 |
InChI: | InChI=1S/C9H18N2/c1-2-8-11(7-1)9-3-5-10-6-4-9/h9-10H,1-8H2 |
InChI Key: | STWODXDTKGTVCJ-UHFFFAOYSA-N |
Boiling Point: | 228.8±8.0°C at 760 mmHg |
Melting Point: | 57-59°C |
Purity: | ≥95% |
Density: | 0.989±0.06 g/cm3 |
Solubility: | Soluble in Methanol |
Appearance: | White Crystal |
Storage: | Store at 2-8°C under inert gas (nitrogen or Argon) |
MDL: | MFCD00035294 |
LogP: | 1.10090 |
GHS Hazard Statement: | H314 (11.11%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P261, P264, P271, P280, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-112898170-A | Preparation method of acid diffusion inhibitor and photoresist composition | 20210122 |
CN-111423454-A | Piperazine compound and application thereof in preparing chemokine receptor CCR2 antagonist | 20200424 |
CN-111423454-B | Piperazine compound and application thereof in preparing chemokine receptor CCR2 antagonist | 20200424 |
WO-2021203016-A2 | Protein-protein interaction stabilizers | 20200403 |
WO-2021194326-A1 | Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulators | 20200327 |
PMID | Publication Date | Title | Journal |
20363703 | 20100401 | Synthesis of some novel analogues of 4-(1-Pyrrolidinyl) Piperidine and their effect on plasma glucose level | Pakistan journal of pharmaceutical sciences |
Complexity: | 113 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 154.146998583 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 154.146998583 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 15.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS